Authors:
Hayhurst, GP
Harlow, J
Chowdry, J
Gross, E
Hilton, E
Lennard, MS
Tucker, GT
Ellis, SW
Citation: Gp. Hayhurst et al., Influence of phenylalanine-481 substitutions on the catalytic activity of cytochrome P450 2D6, BIOCHEM J, 355, 2001, pp. 373-379
Authors:
Ellis, SW
Hayhurst, GP
Lightfoot, T
Smith, G
Harlow, J
Rowland-Yeo, K
Larsson, C
Mahling, J
Lim, CK
Wolf, CR
Blackburn, MG
Lennard, MS
Tucker, GT
Citation: Sw. Ellis et al., Evidence that serine 304 is not a key ligand-binding residue in the activesite of cytochrome P450 2D6, BIOCHEM J, 345, 2000, pp. 565-571
Authors:
Lightfoot, T
Ellis, SW
Mahling, J
Ackland, MJ
Blaney, FE
Bijloo, GJ
De Groot, MJ
Vermeulen, NPE
Blackburn, GM
Lennard, MS
Tucker, GT
Citation: T. Lightfoot et al., Regioselective hydroxylation of debrisoquine by cytochrome P4502D6: implications for active site modelling, XENOBIOTICA, 30(3), 2000, pp. 219-233
Authors:
Schulz-Utermoehl, T
Bennett, AJ
Ellis, SW
Tucker, GT
Boobis, AR
Edwards, RJ
Citation: T. Schulz-utermoehl et al., Polymorphic debrisoquine 4-hydroxylase activity in the rat is due to differences in CYP2D2 expression, PHARMACOGEN, 9(3), 1999, pp. 357-366
Authors:
Marez-Allorge, D
Ellis, SW
Lo Guidice, JM
Tucker, GT
Broly, F
Citation: D. Marez-allorge et al., A rare G(2061) insertion affecting the open reading frame of CYP2D6 and responsible for the poor metabolizer phenotype, PHARMACOGEN, 9(3), 1999, pp. 393-396
Citation: Jcw. Marsh et al., Study of the association between cytochromes P450 2D6 and 2E1 genotypes and the risk of drug and chemical induced idiosyncratic aplastic anaemia, BR J HAEM, 104(2), 1999, pp. 266-270